[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:appendix-adenocarcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":33,"states":34},"Appendix Adenocarcinoma",4,[7,14,21,27],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT05947838","A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma",[],"RECRUITING","2026-08-26T02:16:56.877406Z","2026-05-05T02:43:27.590413Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":19,"content_modified":20},"NCT06207305","A Phase I\u002FII Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma",[18],"Phase 1\u002FPhase 2","2026-08-26T02:15:38.131683Z","2026-05-05T02:43:27.423886Z",{"nct_id":22,"title":23,"phases":24,"status":11,"updated_at":25,"content_modified":26},"NCT06399757","A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors",[18],"2026-08-03T03:48:46.663572Z","2026-05-05T02:43:27.110534Z",{"nct_id":28,"title":29,"phases":30,"status":11,"updated_at":31,"content_modified":32},"NCT07587268","Molecular Profiling for Risk Stratification in Appendiceal Cancer",[],"2026-08-26T02:15:34.659160Z","2026-05-29T15:36:40.198097Z",[],[35],{"state":36,"count":37,"slug":38},"Texas",3,"texas"]